Cargando…
The therapeutic effects of glucagon-like peptide-1 receptor agonists and metformin on polycystic ovary syndrome: A protocol for systematic review and meta-analysis
BACKGROUND: Obesity and insulin resistance (IR) are common in polycystic ovary syndrome (PCOS), which contribute to reproductive and metabolic abnormalities. Metformin increases insulin sensitivity, but it is associated with unsatisfied benefits of weight loss. Recent studies have reported that gluc...
Autores principales: | Ma, Ruilin, Ding, Xuesong, Wang, Yanfang, Deng, Yan, Sun, Aijun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8202615/ https://www.ncbi.nlm.nih.gov/pubmed/34115034 http://dx.doi.org/10.1097/MD.0000000000026295 |
Ejemplares similares
-
Acupuncture combined with metformin for polycystic ovary syndrome: A protocol for systematic review and meta-analysis
por: Sun, Yanan, et al.
Publicado: (2022) -
Auricular therapy for polycystic ovary syndrome: A protocol for a systematic review and meta-analysis
por: Li, Yangyang, et al.
Publicado: (2020) -
Effects of GLP-1 on ovarian dysfunction in polycystic ovary syndrome: A protocol for systematic review and meta-analysis
por: Zhang, Caifeng, et al.
Publicado: (2023) -
Effects of metformin treatment on serum levels of C-reactive protein and interleukin-6 in women with polycystic ovary syndrome: a meta-analysis: A PRISMA-compliant article
por: Wang, Jiao, et al.
Publicado: (2017) -
Association between the persistent organic pollutants and polycystic ovary syndrome: A protocol for a systematic review and meta-analysis
por: Li, Yan, et al.
Publicado: (2019)